The effect of zoledronate during bone healing

Journal of Orthopaedics and Traumatology

Volumn 11, Issue 1, 2010, Pages 7-12

  Matos, Marcos Almeida ^a   Tannuri, Uenis ^b   Guarniero, Roberto ^b  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bisphosphonate; Bone healing; Experimental; Zoledronate

Indexed keywords

ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CALLUS; CONTROLLED STUDY; DRUG EFFECT; FIBROSIS; FRACTURE HEALING; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOMETRY; PERIOSTEUM; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; TRABECULAR BONE;

ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; BONY CALLUS; DIPHOSPHONATES; FIBROSIS; FRACTURE HEALING; IMIDAZOLES; MALE; OSTEOCLASTS; OSTEOTOMY; RABBITS;

EID: 77949657687     PISSN: 15909921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10195-010-0083-1     Document Type: Article

References (20)

1. RGG Russell 2006 Bisphosphonates: from bench to bedside Ann N Y Acad Sci 1068 367 401 10.1196/annals.1346.041 1:CAS:528:DC%2BD28XntFenu7s%3D 16831938 (Pubitemid 43824169)
2. RGG Russell 2007 Bisphosphonates: mode of action and pharmacology Pediatrics 119 S150 S162 10.1542/peds.2006-2023H 17332236 (Pubitemid 46397937)
3. RG Russell PI Croucher MJ Rogers 1999 Bisphosphonates: pharmacology, mechanisms of action and clinical uses Osteoporosis Int 9 566 580 10.1007/PL00004164 (Pubitemid 29231759)
4. JE Madsen T Berg-Larsen OJ Kirkeby JA Falch L Nordsletten 1998 No adverse effects of clodronate on fracyure healing in rats Acta Orthop Scand 69 532 536 1:STN:280:DyaK1M%2FntVyrsw%3D%3D 9855239
5. J Li S Mori Y Kaji J Kawanishi T Akiyama H Norimatsu 2000 Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats J Bone Miner Res 15 2240 2251 10.1359/jbmr.2000.15.10.2042
6. CP Peter WO Cook DM Nunamaker MT Provost JG Seedor GA Rodan 1996 Effect of alendronate on fracture healing and bone remodeling in dogs J Orthop Res 14 79 84 10.1002/jor.1100140113 (Pubitemid 26091605)
7. P Kiely K Ward MC Bellamore J Briody CT Cowell DG Little 2007 Bisphosphonate rescue in distraction osteogenesis: a case series J Pediatr Orthop 27 4 467 471 17513972
8. MA Matos FP Araújo FB Paixão 2007 The effect of zoledronate on bone remodeling during the healing process Acta Cir Bras 22 115 119 17375217
9. MA Matos RR Gonçalves FP Araújo 2001 Experimental model for osteotomy in immature rabbit Acta Ortop Bras 9 4 21 26 10.1590/S1413- 78522001000400003
10. MA Matos FP Araújo FB Paixão 2008 Histomorphometric evaluation of bone healing in rabbit fibular odteotomy model without fixation J Orthop Surg Res 29 3 4 10.1186/1749-799X-3-4
11. AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker 1987 Bone histomorphometry. Standardization of nomeclature, symbols and units J Bone and Miner Res 2 595 610 10.1002/jbmr.5650020617 1:STN:280:DyaL1czjvVemsQ%3D%3D
12. DG Little M Ramachandran A Schindeler 2007 The anabolic and catabolic responses in bone repair J Bone Joint Surg Br 9 4 425 433
13. MM Deckers ER Van Beek G Van Der Pluijim A Wetterwald L Van Der Wee-Pals MG Cecchini SE Papapoulos CW Löwik 2002 Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice J Bone Miner Res 17 998 1007 10.1359/jbmr.2002.17.6.998 12054176
14. AE Goodship PC Walker D McNally T Chambers JR Green 1994 Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bon Ann Oncol 5 Suppl 7 S53 S55 7873463
15. N Amanat M Mcdonald C Godfrey L Bilston D Little 2007 Optimal timing of bolus intravenous zoledronic acid in a rat fracture model J Bone Miner Res 22 6 867 876 10.1359/jbmr.070318 1:CAS:528:DC%2BD2sXpt12jtr0%3D 17371160
16. MM McDonald SK Dulai C Godfrey T Sztynda DG Little 2008 Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling Bone 43 4 653 662 10.1016/j.bone.2008.05.019 1:CAS:528:DC%2BD1cXhtFamsbrK 18582604
17. DG Little M McDonald R Bransford CB Hodfrey N Amanat 2005 Manipulation of the anabolic and catabolic reponses with OP-1 and zoledronic acid in a rat clinical defect model J Bone Miner Res 20 2044 2052 10.1359/JBMR.050712 1:CAS:528:DC%2BD2MXht1amt7bI 16234978 (Pubitemid 41532790)
18. LI Plotkin JI Aguirre S Kousteni SC Manolagas T Bellido 2005 Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanism downstream of extracellular signal-regulated kinase activation J Biol Chem 280 8 7317 7325 10.1074/jbc.M412817200 1:CAS:528:DC%2BD2MXhsFSjsrc%3D 15590626 (Pubitemid 40341290)
19. LI Plotkin RS Weinstein AM Parfitt PK Roberson SC Manolagas T Bellido 1999 Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin J Clin Invest 104 10 1363 1374 10.1172/JCI6800 1:CAS:528: DyaK1MXntlyru7k%3D 10562298
20. C Wedemeyer F Von Knoch A Pingsmann G Hilken C Sprecher G Saxler F Henschke F Loer M Von Knoch 2005 Stimulation of bone formation by zoledronic acid in particle induced osteolysis Biomaterials 17 3719 3727 10.1016/j.biomaterials.2004.09.026 (Pubitemid 40038167)